A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Jul 2005
- 410-21 p. digital